Role of eIF4E on epithelial-mesenchymal transition, invasion, and chemoresistance of prostate cancer cells
Xujie Liu
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorAmita M Vaidya
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorDa Sun
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorYan Zhang
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorNadia Ayat
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorAndrew Schilb
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorCorresponding Author
Zheng-Rong Lu
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Correspondence
Zheng-Rong Lu; M. Frank Rudy and Margaret Domiter Rudy Professor of Biomedical Engineering; Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.
Email: [email protected].
Search for more papers by this authorXujie Liu
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorAmita M Vaidya
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorDa Sun
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorYan Zhang
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorNadia Ayat
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorAndrew Schilb
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Search for more papers by this authorCorresponding Author
Zheng-Rong Lu
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106 USA
Correspondence
Zheng-Rong Lu; M. Frank Rudy and Margaret Domiter Rudy Professor of Biomedical Engineering; Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.
Email: [email protected].
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| cac212011-sup-0001-SupMat.docx378.3 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Siegel Rebecca L., Miller Kimberly D., Jemal Ahmedin Cancer statistics, 2019. CA: A Cancer Journal for Clinicians. 2019; 69(1): 7–34. https://doi.org/10.3322/caac.21551.
- 2Boutros PC, Fraser M, Harding NJ, De Borja R, Trudel D, Lalonde E, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet 2015; 47(7): 736.
- 3Molejon MI, Tellechea JI, Loncle C, Gayet O, Gilabert M, Duconseil P, et al. Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Oncotarget 2015; 6(10): 7408.
10.18632/oncotarget.3510 Google Scholar
- 4D'Abronzo LS, Ghosh PM. eIF4E Phosphorylation in Prostate Cancer. Neoplasia 2018; 20(6): 563–73.
- 5Gujrati M, Vaidya AM, Mack M, Snyder D, Malamas A, Lu Z. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy. Adv Healthc Mater 2016; 5(22): 2882–95.
- 6Robichaud N, Del RS, Huor B, Alain T, Petruccelli LA, Hearnden J, et al. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene 2015; 34(16): 2032–42.
- 7Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, et al. EMT and tumor metastasis. Clinical and Translational Medicine 2015; 4(1).
- 8Sun D, Sahu B, Gao S, Schur RM, Vaidya AM, Maeda A, et al. Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis. Molecular Therapy - Nucleic Acids 2017; 7: 42–52.
10.1016/j.omtn.2017.02.005 Google Scholar
- 9Sun D, Maeno H, Gujrati M, Schur R, Maeda A, Maeda T, et al. Self-Assembly of a Multifunctional Lipid With Core-Shell Dendrimer DNA Nanoparticles Enhanced Efficient Gene Delivery at Low Charge Ratios into RPE Cells. Macromol Biosci 2015; 15(12): 1663–72.
- 10Vaidya AM, Sun Z, Ayat N, Schilb A, Liu X, Jiang H, et al. Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy. Bioconjugate Chem 2019; 30(3): 907–19.
10.1021/acs.bioconjchem.9b00028 Google Scholar
- 11Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 2018; 15(2): 81–94.
